FORM 6

FORM 6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Report of Foreign Private Issuer

Pursuant to Rule 13a - 16 or 15d - 16 of

the Securities Exchange Act of 1934

 

For the month of April, 2003

Commission File Number: 1-10817

 

CELLTECH GROUP PLC

(Translation of registrant's name into English)

 

208 Bath Road, Slough, Berkshire SL1 3WE ENGLAND

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F X      Form 40-F

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes          No X

 

(If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-________).

 

 

Enclosure: Holding(s) in Company released 30 April, 2003

 

SCHEDULE 10

NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Name of company

Celltech Group plc

2. Name of shareholder having a major interest

FMR Corp. and its direct and indirect subsidiaries and Fidelity International Limited and its direct and indirect subsidiaries

3. Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18

As in 2 above

4. Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them

   

State Street Nominees Limited

147,412

Mellon Bank

13,418

Chase Nominees Limited

1,828,588

HSBC

469,700

State Street Bank & Trust Company

271,400

State Street Bank & Trust

59,600

Chase Nominees

6,254,251

Citibank

119,800

Deutsche Bank

29,600

HSBC

59,214

Bank of New York London

100,400

Chase Nominees Limited

693,720

Northern Trust

152,600

Chase Nominees

385,100

Nortrust Nominees Ltd

385,526

HSBC Client Holdings Nominee (UK) Limited

11,814,170

Chase Manhattan Bank London

570,737

Northern Trust

963,382

JP Morgan

291,811

Bank of New York London

831,800

Morgan Stanley

237,100

Deutsche Bank

172,600

Mellon Nominees Ltd

36,900

State Street Nominees Ltd

166,200

Bank of New York Brussels

366,141

State Street Bank & Trust

443,172

Chase Nominees Ltd

769,700

Nortrust Nominees Ltd

232,500

HSBC Client Holdings Nominee (UK) Limited

200

 

5. Number of shares / amount of stock acquired

2,702,046 (since last notification)

6. Percentage of issued class

0.97%

7. Number of shares / amount of stock disposed

N/a

8. Percentage of issued class

N/a

9. Class of security

Ordinary 50p shares

10. Date of transaction

29 April 2003

 

 

11. Date company informed

30 April 2003

12. Total holding following this notification

27,866,742

13. Total percentage holding of issued class following this notification

10.04%

14. Any additional information

 

 

15. Name of contact and telephone number for queries

Cheryl Cramer

Tel. 01753 447933

16. Name and signature of authorised company official responsible for making this notification

Cheryl Cramer

Date of notification

30 April 2003

The FSA does not give any express or implied warranty as to the accuracy of this document or material and does not accept any liability for error or omission. The FSA is not liable for any damages (including, without limitation, damages for loss of business or loss of profits) arising in contract, tort or otherwise from the use of or inability to use this document, or any material contained in it, or from any action or decision taken as a result of using this document or any such material.

END

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

                                                                                                                                                           CELLTECH GROUP PLC
                                                                                                                                                           (Registrant)

 

 

                                                                                                                                                           By: /s/ PETER ALLEN       
                                                                                                                                                           Peter Allen
                                                                                                                                                           Chief Financial Officer

 

Dated: 30 April, 2003